Life Science Investing Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
Life Science Investing Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Freegold Reports Final 2024 Drilling Results from Golden Summit Continuing to Confirm Higher Grade Potential
Group Eleven Intersects 12.0m of 2.30% Cu and 560 g/t Ag, Including 6.4m of 3.72% Cu and 838 g/t Ag, Demonstrating High-Grade Copper and Silver Potential at Ballywire
